Benchmark lowered the firm’s price target on Marcus (MCS) to $22 from $25 and keeps a Buy rating on the shares. Cnsistent with industry-wide exhibition weakness, the firm expects a softer fiscal Q3 for Marcus, followed by a meaningful rebound in fiscal Q4 as the release slate strengthens, the analyst tells investors.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MCS:
- Marcus Corp: Positioned for Multiyear Recovery with Strong Film Slate and Strategic Fiscal Shift
- Marcus Corporation: Strong Market Position and Growth Potential with Strategic Investments and Resilient Performance
- Taylor Swift plans return to movie theaters, Hollywood Reporter says
- Marcus management to meet with Benchmark
- Marcus Appoints Paul A. Leff to Board